35604-67-2,MFCD00661100
Catalog No.:AA00C8UI

35604-67-2 | 2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
1 week  
$79.00   $55.00
- +
250mg
98%
1 week  
$132.00   $92.00
- +
1g
98%
1 week  
$287.00   $201.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C8UI
Chemical Name:
2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride
CAS Number:
35604-67-2
Molecular Formula:
C13H20ClNO3
Molecular Weight:
273.7558
MDL Number:
MFCD00661100
SMILES:
CCOc1ccccc1OCC1CNCCO1.Cl
Properties
Computed Properties
 
Complexity:
213  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  

Synonyms
 
604E672  
Literature

Title: Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.

Journal: Scientific reports 20160101

Title: A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.

Journal: Journal of the American College of Surgeons 20080501

Title: Effects of administration route on pharmacokinetics of viloxazine in the rabbit.

Journal: Methods and findings in experimental and clinical pharmacology 19920301

Title: Comparative pharmacokinetic study of conventional and sustained-release viloxazine in normal volunteers.

Journal: Neuropsychobiology 19890101

Title: [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].

Journal: Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952) 19860101

Title: [Behavioral and radioreceptor analysis of viloxazine stereoisomers].

Journal: Biulleten' eksperimental'noi biologii i meditsiny 19840501

Title: Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.

Journal: Neuropsychobiology 19840101

Title: Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.

Journal: Advances in biochemical psychopharmacology 19820101

Title: Pharmacokinetics of viloxazine hydrochloride in man.

Journal: European journal of drug metabolism and pharmacokinetics 19820101

Title: Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Journal: Drugs 19770601

Title: Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.

Journal: Canadian journal of physiology and pharmacology 19760801

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:35604-67-2 Molecular Formula|35604-67-2 MDL|35604-67-2 SMILES|35604-67-2 2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride
Catalog No.: AA00C8UI
35604-67-2,MFCD00661100
35604-67-2 | 2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride
Pack Size: 100mg
Purity: 98%
1 week
$79.00 $55.00
Pack Size: 250mg
Purity: 98%
1 week
$132.00 $92.00
Pack Size: 1g
Purity: 98%
1 week
$287.00 $201.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C8UI
Chemical Name: 2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride
CAS Number: 35604-67-2
Molecular Formula: C13H20ClNO3
Molecular Weight: 273.7558
MDL Number: MFCD00661100
SMILES: CCOc1ccccc1OCC1CNCCO1.Cl
Properties
Complexity: 213  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
66: 604E672  
Literature fold

Title: Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.

Journal: Scientific reports20160101

Title: A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.

Journal: Journal of the American College of Surgeons20080501

Title: Effects of administration route on pharmacokinetics of viloxazine in the rabbit.

Journal: Methods and findings in experimental and clinical pharmacology19920301

Title: Comparative pharmacokinetic study of conventional and sustained-release viloxazine in normal volunteers.

Journal: Neuropsychobiology19890101

Title: [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].

Journal: Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)19860101

Title: [Behavioral and radioreceptor analysis of viloxazine stereoisomers].

Journal: Biulleten' eksperimental'noi biologii i meditsiny19840501

Title: Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.

Journal: Neuropsychobiology19840101

Title: Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.

Journal: Advances in biochemical psychopharmacology19820101

Title: Pharmacokinetics of viloxazine hydrochloride in man.

Journal: European journal of drug metabolism and pharmacokinetics19820101

Title: Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Journal: Drugs19770601

Title: Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.

Journal: Canadian journal of physiology and pharmacology19760801

Building Blocks More >
32449-80-2
32449-80-2
Glucuronic acid, γ-lactone, L- (8CI)
AA00C8Z2
34862-03-8
34862-03-8
2-METHYL-2-PHENYLSUCCINICACID
AA00C950 | MFCD00021683
344299-41-8
344299-41-8
1-BroMo-2-Methylpropane-d7
AA00C9BE | MFCD29050310
383417-48-9
383417-48-9
N'-Nitrosopentyl-(2-picolyl)amine
AA00C9HE | MFCD01320442
341988-36-1
341988-36-1
Methyl indoline-6-carboxylate
AA00C9OC | MFCD07371629
36913-39-0
36913-39-0
MPP+ IODIDE
AA00C9V2 | MFCD00055096
40453-80-3
40453-80-3
1-Fluoro-3-methoxy-2-propanol
AA00CA20 | MFCD04972881
381723-16-6
381723-16-6
2-ETHYNYL-1,3-DIFLUORO-BENZENE
AA00CAER | MFCD08703481
364758-55-4
364758-55-4
6-(4-Fluorophenoxy)pyridin-3-ol
AA00CASX | MFCD22571026
22431-45-4
22431-45-4
Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4β-propyl-2α-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside
AA00CBNO
Submit
© 2017 AA BLOCKS, INC. All rights reserved.